FSLY vs GILD · rev $356.3M vs P/E 18, rev $7.80B
Fastly, Inc. Class A Common Stock (FSLY) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Fastly, Inc. Class A Common Stock (FSLY) is a software - application company listed on NASDAQ.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FSLY revenue for 2026-06-30 was $356.3M. Net income was -$36.1M. FSLY currently screens at market cap $2.72B.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FSLY currently screens at market cap $2.72B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FSLY and GILD stock pages for the full models.
Not investment advice.